JP2021529752A5 - - Google Patents

Info

Publication number
JP2021529752A5
JP2021529752A5 JP2020572891A JP2020572891A JP2021529752A5 JP 2021529752 A5 JP2021529752 A5 JP 2021529752A5 JP 2020572891 A JP2020572891 A JP 2020572891A JP 2020572891 A JP2020572891 A JP 2020572891A JP 2021529752 A5 JP2021529752 A5 JP 2021529752A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
group
heteroaryl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020572891A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021529752A (ja
JP7396682B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/040121 external-priority patent/WO2020006557A1/en
Publication of JP2021529752A publication Critical patent/JP2021529752A/ja
Publication of JP2021529752A5 publication Critical patent/JP2021529752A5/ja
Application granted granted Critical
Publication of JP7396682B2 publication Critical patent/JP7396682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020572891A 2018-06-29 2019-07-01 イタコン酸誘導体の組成物及び使用方法 Active JP7396682B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862763735P 2018-06-29 2018-06-29
US62/763,735 2018-06-29
PCT/US2019/040121 WO2020006557A1 (en) 2018-06-29 2019-07-01 Compositions and methods of using itaconic acid derivatives

Publications (3)

Publication Number Publication Date
JP2021529752A JP2021529752A (ja) 2021-11-04
JP2021529752A5 true JP2021529752A5 (cg-RX-API-DMAC7.html) 2022-06-21
JP7396682B2 JP7396682B2 (ja) 2023-12-12

Family

ID=68985877

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020572891A Active JP7396682B2 (ja) 2018-06-29 2019-07-01 イタコン酸誘導体の組成物及び使用方法

Country Status (5)

Country Link
US (1) US12060310B2 (cg-RX-API-DMAC7.html)
EP (1) EP3813815B1 (cg-RX-API-DMAC7.html)
JP (1) JP7396682B2 (cg-RX-API-DMAC7.html)
ES (1) ES3063485T3 (cg-RX-API-DMAC7.html)
WO (1) WO2020006557A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL287444B2 (en) 2019-04-30 2024-09-01 Sitryx Therapeutics Ltd Itaconic acid derivatives and uses thereof in treating an inflammatory disease or a disease associated with an undesirable immune response
FI4081511T6 (fi) 2019-12-23 2026-06-09 Sitryx Therapeutics Ltd Karboksijohdannaisia, joilla on anti-inflammatorisia ominaisuuksia
EP4237404A1 (en) * 2020-10-29 2023-09-06 Sitryx Therapeutics Limited Novel compounds
EP4326247A1 (en) 2021-04-23 2024-02-28 Helmholtz-Zentrum für Infektionsforschung GmbH Citraconic acid and derivatives thereof for use as a medicament
CN119685257B (zh) * 2024-12-16 2026-02-27 华中科技大学同济医学院附属协和医院 体外诱导t细胞免疫记忆分化的方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260479A (en) * 1991-12-16 1993-11-09 Merck & Co., Inc. Inhibitors of farnesyl protein transferase
DK1062954T3 (da) * 1998-10-27 2007-09-10 Suntory Ltd Anvendelse af itakonsyre til regulering af det glykotiske stofskifte
US8293925B2 (en) * 2009-09-21 2012-10-23 Chemocentryx, Inc. Pyrrolidinone carboxamide derivatives
LU91877B1 (en) 2011-09-23 2013-03-25 Univ Luxembourg Method to predict the presence of itaconic Acid, IRG1 and/or protein IRG1 in a subject and pharmaceutical composition for performing gene therapy
US8691993B2 (en) * 2011-12-12 2014-04-08 Hoffmann-La Roche Inc. Piperidinyl naphthylacetic acids
WO2013150534A1 (en) * 2012-04-03 2013-10-10 Aposense Ltd. Novel targeting agents for diagnostic and therapeutic indications
EP3416634A4 (en) * 2016-02-15 2019-10-09 Artyomov, Maxim IMMUNOMODULATORY AGENTS AND METHOD FOR USE THEREOF

Similar Documents

Publication Publication Date Title
JP2018519343A5 (cg-RX-API-DMAC7.html)
CA2324418A1 (en) Novel opiate compounds, methods of making and methods of use
AR078542A1 (es) Moduladores de gpr40 de pirrolidina
RU2015148010A (ru) Высокоактивное производное нуклеозида для лечения hcv
CA2565599A1 (en) Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
JP2022521797A5 (cg-RX-API-DMAC7.html)
ME02875B (me) Inhibitori hcv polimeraze
PE20090630A1 (es) Derivados de indol 2-carboxi sustituidos y metodos para su utilizacion
AR053195A1 (es) Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo
PE20070751A1 (es) Derivados de isoxazolidina como inhibidores de la interaccion de proteinas bcl
RU2010116253A (ru) Производные n-гидроксилсульфонамида как новые физиологически применимые доноры нитроксила
AR037355A1 (es) Compuesto derivado de difenilamina, composicion farmaceutica y su uso en la fabricacion de medicamentos
RU2011140064A (ru) Ингибиторы тирозинкиназы брутона
RU2008143001A (ru) 5-амидозамещенные пиримидины, ингибирующие вич
AR067896A1 (es) Procedimiento para sintetizar compuestos utiles para tratar hepatitis c
RU2010106393A (ru) Новые микробиоциды
CA2439410A1 (en) Analogs of thalidomide as potential angiogenesis inhibitors
AR049124A1 (es) Compuestos de de pirimidinona como inhibidores de la integrasa del virus hiv, composiciones farmaceuticas que las contienen y su uso en el tratamiento del sida y de la infeccion por hiv
RU2008152087A (ru) Макроциклические оксимильные ингибиторы протеазы гепатита
WO2008078196A3 (en) Substituted heteroaryl pyridopyrimidone derivatives
AR086590A1 (es) Compuestos de ciclohexanona y herbicidas que los comprenden
JP2008518900A5 (cg-RX-API-DMAC7.html)
JP2023504542A5 (cg-RX-API-DMAC7.html)
RU2010130418A (ru) Производные 4-аминопиримидина
AR046782A1 (es) Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos.